Karla Kerlikowske, MD

Professor, Departments of Medicine and Epidemiology/Biostatistics, UCSF

karla.kerlikowske@ucsf.edu

Phone: (415) 750-2093 (voice)
VAMC 111A1, San Francisco, CA 94143

View on UCSF Profiles

Education

Michigan State University, East Lansing, BS, 1978, Medical Technology
University of California, Berkeley, MS, 1984, Nutrition
University of California San Francisco, MD, 1988, Medicine

Professional Experience

• 1988-89
  Medicine Internship, University of California San Francisco, San Francisco, CA
• 1989-91
  Primary Care Medicine Residency, University of California San Francisco, San Francisco, CA
• 1991-93
  Fellow in General Internal Medicine, Veterans Affairs Medical Center, San Francisco, CA
• 1991-93
  Clinical Instructor, Assistant Physician, UCSF Department of Medicine, San Francisco, CA
• 1993-1999
  Associate Director, Women's Clinic, Veterans Affairs Medical Center, San Francisco, CA
• 1999-present
  Director, Women's Clinic, Veterans Affairs Medical Center, San Francisco, CA
• 1994-present
  Assistant Professor In Residence, UCSF Department of Medicine, San Francisco, CA
• 1994-present
  Assistant Professor In Residence, UCSF Department of Epidemiology & Biostatistics, San Francisco, CA
• 2000-present
  Associate Professor, In Residence, Department of Medicine, Univ. of California, San Francisco
• 2000-present
  Associate Professor, In Residence, Department of Epidemiology & Biostatistics, Univ. of California, San Francisco
• 2000-present
  Professor, In Residence, Department of Epidemiology & Biostatistics, Univ. of California, San Francisco

Honors & Awards

• 1975
  Tower Guard Award for Scholastic Achievement
• 1975-77
  Honors College, Michigan State University
• 1978
  Magna cum laude, Michigan State University
• 1986
  Student Summer Research Fellowship, UCSF
• 1987
  Alpha Omega Alpha
• 1994-96
  American Cancer Society Award for Primary Care Physicians

Selected Publications

1. Goldman LE, Walker R, Hubbard R, Kerlikowske K. Timeliness of Abnormal Screening and Diagnostic Mammography Follow-up at Facilities Serving Vulnerable Women. Med Care. 2013 Apr; 51(4):307-14.
   View on PubMed
2. Houssami N, Abraham LA, Kerlikowske K, Buist DS, Irwig L, Lee J, Miglioretti DL. Risk factors for second screen-detected or interval breast cancers in women with a personal history of breast cancer participating in mammography screening. Cancer Epidemiol Biomarkers Prev. 2013 May; 22(5):946-61.
   View on PubMed
3. Braithwaite D, Zhu W, Hubbard RA, O'Meara ES, Miglioretti DL, Geller B, Dittus K, Moore D, Wernli KJ, Mandelblatt J, Kerlikowske K. Screening Outcomes in Older US Women Undergoing Multiple Mammograms in Community Practice: Does Interval, Age, or Comorbidity Score Affect Tumor Characteristics or False Positive Rates? J Natl Cancer Inst. 2013 Mar 6; 105(5):334-41.
   View on PubMed
4. Harvey JA, Gard CC, Miglioretti DL, Yankaskas BC, Kerlikowske K, Buist DS, Geller BA, Onega TL. Reported mammographic density: film-screen versus digital acquisition. Radiology. 2013 Mar; 266(3):752-8.
   View on PubMed
5. Smith RA, Kerlikowske K, Miglioretti DL, Kalager M. Clinical decisions. Mammography screening for breast cancer. N Engl J Med. 2012 Nov 22; 367(21):e31.
   View on PubMed
6. Onega T, Smith M, Miglioretti DL, Carney PA, Geller BA, Kerlikowske K, Buist DS, Rosenberg RD, Smith RA, Sickles EA, Haneuse S, Anderson ML, Yankaskas B. Radiologist agreement for mammographic recall by case difficulty and finding type. J Am Coll Radiol. 2012 Nov; 9(11):788-94.
   View on PubMed
7. Braithwaite D, Izano M, Moore DH, Kwan ML, Tammemagi MC, Hiatt RA, Kerlikowske K, Kroenke CH, Sweeney C, Habel L, Castillo A, Weltzien E, Caan B. Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review. Breast Cancer Res Treat. 2012 Nov; 136(2):521-33.
   View on PubMed
8. Gierach GL, Ichikawa L, Kerlikowske K, Brinton LA, Farhat GN, Vacek PM, Weaver DL, Schairer C, Taplin SH, Sherman ME. Relationship between mammographic density and breast cancer death in the Breast Cancer Surveillance Consortium. J Natl Cancer Inst. 2012 Aug 22; 104(16):1218-27.
   View on PubMed
9. DeFilippis RA, Chang H, Dumont N, Rabban JT, Chen YY, Fontenay GV, Berman HK, Gauthier ML, Zhao J, Hu D, Marx JJ, Tjoe JA, Ziv E, Febbraio M, Kerlikowske K, Parvin B, Tlsty TD. CD36 repression activates a multicellular stromal program shared by high mammographic density and tumor tissues. Cancer Discov. 2012 Sep; 2(9):826-39.
   View on PubMed
10. Yasmeen S, Hubbard RA, Romano PS, Zhu W, Geller BM, Onega T, Yankaskas BC, Miglioretti DL, Kerlikowske K. Risk of advanced-stage breast cancer among older women with comorbidities. Cancer Epidemiol Biomarkers Prev. 2012 Sep; 21(9):1510-9.
    View on PubMed
11. Nelson HD, Zakher B, Cantor A, Fu R, Griffin J, O'Meara ES, Buist DS, Kerlikowske K, van Ravesteyn NT, Trentham-Dietz A, Mandelblatt JS, Miglioretti DL. Risk factors for breast cancer for women aged 40 to 49 years: a systematic review and meta-analysis. Ann Intern Med. 2012 May 1; 156(9):635-48.
    View on PubMed
12. van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DS, Huang H, Heijnsdijk EA, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD, Mandelblatt JS, de Koning HJ. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med. 2012 May 1; 156(9):609-17.
    View on PubMed
13. Carney PA, Bogart TA, Geller BM, Haneuse S, Kerlikowske K, Buist DS, Smith R, Rosenberg R, Yankaskas BC, Onega T, Miglioretti DL. Association between time spent interpreting, level of confidence, and accuracy of screening mammography. AJR Am J Roentgenol. 2012 Apr; 198(4):970-8.
    View on PubMed
14. Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, O'Meara ES, Li CI. Breast density, body mass index, and risk of tumor marker-defined subtypes of breast cancer. Ann Epidemiol. 2012 May; 22(5):340-8.
    View on PubMed
15. Karliner LS, Ma L, Hofmann M, Kerlikowske K. Language barriers, location of care, and delays in follow-up of abnormal mammograms. Med Care. 2012 Feb; 50(2):171-8.
    View on PubMed
16. Buist DS, Walker R, Bowles EJ, Carney PA, Taplin SH, Onega T, Kerlikowske K, Clinton W, Miglioretti DL. Screening mammography use among current, former, and never hormone therapy users may not explain recent declines in breast cancer incidence. Cancer Epidemiol Biomarkers Prev. 2012 May; 21(5):720-7.
    View on PubMed
17. Kerlikowske K. Screening mammography in women less than age 50 years. Curr Opin Obstet Gynecol. 2012 Feb; 24(1):38-43.
    View on PubMed
18. Shepherd JA, Kerlikowske K. Do fatty breasts increase or decrease breast cancer risk? Breast Cancer Res. 2012; 14(1):102.
    View on PubMed
19. Lorizio W, Wu AH, Beattie MS, Rugo H, Tchu S, Kerlikowske K, Ziv E. Clinical and biomarker predictors of side effects from tamoxifen. Breast Cancer Res Treat. 2012 Apr; 132(3):1107-18.
    View on PubMed
20. Haneuse S, Buist DS, Miglioretti DL, Anderson ML, Carney PA, Onega T, Geller BM, Kerlikowske K, Rosenberg RD, Yankaskas BC, Elmore JG, Taplin SH, Smith RA, Sickles EA. Mammographic interpretive volume and diagnostic mammogram interpretation performance in community practice. Radiology. 2012 Jan; 262(1):69-79.
    View on PubMed

View on UCSF Profiles